Tuesday, March 20, 2018 5:02:30 PM
As per 10-Q 11/14/17:
525,000,000 shares authorized, 243,136,285 and 181,804,501 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively
The company is funding itself by issuing more authorized shares. The 10-Q shows how every month of 2017 they did so for anything form services rendered to simply funding cash.
They still have well over 200M to issue. That has been, and should continue to be their source of funding.
525,000,000 shares authorized, 243,136,285 and 181,804,501 shares issued and outstanding as of September 30, 2017 and December 31, 2016, respectively
The company is funding itself by issuing more authorized shares. The 10-Q shows how every month of 2017 they did so for anything form services rendered to simply funding cash.
They still have well over 200M to issue. That has been, and should continue to be their source of funding.
Recent BICX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 01:31:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 07:31:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 07:04:16 PM
- BioCorRx Inc. to Present at the Life Sciences Virtual Investor Forum December 11th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Life Sciences Virtual Investor Forum Agenda Announced for December 11th • GlobeNewswire Inc. • 12/09/2025 01:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:28:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 05:59:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2025 08:15:38 PM
